Randomized phase II study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG0805).

Abstract

A randomized Phase II selection design trial comparing gemcitabine plus S-1 combination therapy with S-1 monotherapy for chemo-naïve unresectable or recurrent biliary tract cancer patients was started in Japan. The aim of this trial is to evaluate the efficacy and safety of the two regimens and to determine which is more promising as a test arm regimen to… (More)
DOI: 10.1093/jjco/hyq110

Topics

Cite this paper

@article{Takashima2010RandomizedPI, title={Randomized phase II study of gemcitabine plus S-1 combination therapy vs. S-1 in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG0805).}, author={Atsuo Takashima and Chigusa Morizane and Hiroshi Ishii and Kenichi Nakamura and Haruhiko Fukuda and Takuji Okusaka and Junji Furuse}, journal={Japanese journal of clinical oncology}, year={2010}, volume={40 12}, pages={1189-91} }